Science & Research
Ascentage Pharma Advances Global Phase III Trial for Lisaftoclax in Higher-Risk MDS Treatment
Ascentage Pharma's GLORA-4 Phase III trial of lisaftoclax, a potential breakthrough for higher-risk myelodysplastic syndrome (MDS), receives FDA and EMA clearance, marking a significant step towards addressing a critical unmet medical need in oncology.
University of Rochester Researchers Develop Novel Material to Enhance Solar Energy Generation
A breakthrough in solar thermoelectric generators (STEGs) by University of Rochester researchers promises to significantly boost efficiency and energy generation, potentially impacting companies like PowerBank Corporation.
Soligenix Inc. Receives FDA Orphan Drug Designation for Dusquetide in Behçet’s Disease
Soligenix Inc. has been granted FDA orphan drug designation for dusquetide, a significant step forward in treating Behçet’s Disease, highlighting the potential for new therapies in rare diseases.
GeoVax to Showcase Mpox Vaccine Progress at Emerging Growth Conference
GeoVax Labs, Inc. will present updates on its GEO-MVA Mpox vaccine development at the Emerging Growth Conference, highlighting potential regulatory acceleration and manufacturing advantages.
Creative Biolabs Advances Antibody Non-GMP Production and Quality Control
Creative Biolabs is addressing the critical need for high-quality, research-grade antibodies and specialized quality control services in the therapeutic antibody development sector.
IndyGeneUS Bio Wins National Recognition for Inclusive Genomics Research
IndyGeneUS Bio, a Baltimore-based life sciences startup, has been awarded first place in the Disabled American Veterans Pitch Competition for its efforts to make genomic research more inclusive for underserved populations.
Everyday Strategies to Enhance Brain Health and Cognitive Function
Exploring simple, effective methods to maintain and improve brain health through mental stimulation, diet, mental wellness, and physical activity.
Simulated Environment Concepts Announces Breakthrough in Livestock Production with Structured Water Technology
Simulated Environment Concepts, Inc. reveals promising results from a trial using structured water in cattle, indicating potential to revolutionize livestock production amidst industry challenges.
Study Reveals B-Vitamin Supplements Could Offer New Hope for Parkinson’s Disease Patients
A recent study highlights the potential of B-vitamin supplements in addressing some medical needs of Parkinson’s disease patients, suggesting a simple yet effective treatment option.
Clene Inc. to Share Corporate Update at Emerging Growth Conference
Clene Inc. is set to present a corporate update at the Emerging Growth Conference, highlighting its progress in developing treatments for neurodegenerative diseases.
Japan Achieves Milestone with First Domestically Made Quantum Computer
Japan's unveiling of a domestically produced quantum computer signifies a major advancement in the country's technology sector and its ambitions in the global quantum computing race.
Creative Biolabs Enhances Gene Therapy Research with Expanded Liposomal Drug Delivery Services
Creative Biolabs has expanded its liposomal drug delivery services to support advancements in gene therapy, oncology, and molecular medicine, offering customized solutions for research institutions and pharmaceutical industries worldwide.
Cybin Inc. Advances Mental Health Treatments with Q1 2025 Results and Key Program Updates
Cybin Inc. reports significant progress in its Phase 3 depression program and Phase 2 anxiety study, highlighting advancements in next-generation mental health treatments.
Clene Inc. Advances Toward FDA Submission for ALS Therapy with Promising Q2 2025 Results
Clene Inc. reports significant progress in its Q2 2025 results, targeting a year-end NDA submission for its ALS therapy, CNM-Au8, with sufficient cash runway into Q1 2026.
Intensity Therapeutics Pioneers New Cancer Treatment with Minimal Side Effects
Intensity Therapeutics is advancing a novel cancer treatment that directly targets tumors with minimal side effects, offering hope for patients with refractory solid tumors.
Understanding the Risks and Treatments of Benign Brain Tumors in Women
This article highlights the increased risk of benign brain tumors in women and the importance of recognizing early symptoms, while also discussing current treatment options and ongoing research efforts.
New High Blood Pressure Guideline Focuses on Prevention and Early Treatment to Combat CVD Risk
A joint guideline by the American Heart Association and the American College of Cardiology emphasizes early treatment and lifestyle changes to manage high blood pressure, aiming to reduce the risk of cardiovascular diseases and cognitive decline.
Maryland's Research Sector at Risk as Federal Funding Cuts Loom
The article explores the potential economic and scientific repercussions of federal funding cuts on Maryland's research institutions and biotech industry, highlighting the urgent need for state intervention.
New Satellite Orbit Determination Method Enhances Navigation Precision for Mega-Constellations
A breakthrough in satellite precise orbit determination method significantly improves navigation accuracy for future mega-constellations by reducing reliance on ground stations and correcting systematic rotation errors.
Revolutionary Hydrogel Cubes Offer New Frontier in Dynamic Data Storage
Researchers have developed a LEGO-like hydrogel system capable of storing over 800 billion data configurations, revolutionizing dynamic data storage and secure encoding.
Glidelogic Corp. Launches Advanced AI-Powered ResearchMind Platform Globally
Glidelogic Corp. has globally launched its upgraded ResearchMind platform, integrating advanced AI technologies to enhance academic research and hypothesis formation.
CNS Pharmaceuticals Inc. Advances TPI 287 Toward Phase 2 GBM Trial Amid Improved Financials
CNS Pharmaceuticals Inc. reports a slight improvement in Q2 2025 financials, with reduced net losses and increased R&D expenses as it prepares for a Phase 2 trial of TPI 287 for glioblastoma multiforme, highlighting the drug's potential to cross the blood-brain barrier and treat CNS tumors.
New Study Challenges Traditional Psoriasis Severity Classifications
Recent research indicates that psoriasis affecting less than 3% of body surface area may still impose a significant disease burden, prompting a reevaluation of current treatment approaches.
Torr Metals Inc. Unveils High-Grade Copper Discovery and Untested Porphyry Target at Kolos Project
Torr Metals Inc. reports significant high-grade copper findings and identifies a major untested porphyry target at its Kolos Copper-Gold Project in British Columbia, signaling potential for substantial mineral resource expansion.
Soligenix Advances Heat-Stable Ricin Vaccine Amid Global Biothreat Concerns
Soligenix Inc. is progressing with RiVax®, a heat-stable vaccine against ricin toxin, showcasing significant potential in biodefense and public safety.
AAA Biotech Expands Recombinant Proteins Portfolio to Advance Life Sciences Research
AAA Biotech enhances its recombinant proteins portfolio, offering high-quality research reagents to support groundbreaking biomedical research.
The Strategic Advantages of Collaborating with Established Clinical Research Teams
Exploring the multifaceted benefits organizations gain by partnering with experienced clinical research teams, from ensuring high-quality, ethical studies to fostering innovation and compliance with regulations.
Transformational $3 Million Gift to Advance Women's Heart Health
A $3 million donation from Lee and Valerie Shapiro to the American Heart Association aims to enhance women's heart health through research and awareness campaigns.
Oragenics Inc. Advances Toward Phase IIa Concussion Trial with ONP-002
Oragenics Inc. (NYSE American: OGEN) is making significant progress with its lead candidate, ONP-002, aiming to become the first FDA-approved pharmacological treatment for concussion, highlighting the potential of its intranasal delivery technology in transforming neurological care.
New Study Offers Hope for Pediatric Glioma Treatment
A collaborative study between the Broad Institute and the Dana-Farber Cancer Institute has identified a promising treatment approach for pediatric gliomas using FDA-approved inhibitors.